Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TDP1 is involved in repairing stalled topoisomerase I-DNA complexes by catalyzing the hydrolysis of the phosphodiester bond between the tyrosine residue of topoisomerase I and the 3-prime phosphate of DNA. Additionally we are shipping TDP1 Proteins (14) and TDP1 Kits (3) and many more products for this protein.
Showing 10 out of 103 products:
Human Polyclonal TDP1 Primary Antibody for ELISA, WB - ABIN565920
Katyal, el-Khamisy, Russell, Li, Ju, Caldecott, McKinnon: TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. in The EMBO journal 2007
Show all 5 Pubmed References
Human Polyclonal TDP1 Primary Antibody for IHC (p), IP - ABIN257087
Perego, Cossa, Tinelli, Corna, Carenini, Gatti, De Cesare, Ciusani, Zunino, Luison, Canevari, Zaffaroni, Beretta: Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition. in Biochemical pharmacology 2011
Show all 2 Pubmed References
We found the rs942190 GG genotype of TDP1 to be associated with relatively poor survival among small-cell lung cancer patients. Further investigation is needed to confirm the result and to determine whether this genotype may be a predictive marker for treatment efficacy of DNA topoisomerase inhibitors
this study identifies the importance of TDP1 as a novel determinant of response to CNDAC across various cancer types (especially non-small cell lung cancers), and demonstrates the differential involvement of BRCA2 (show BRCA2 Antibodies), PARP1 (show PARP1 Antibodies), and TDP1 in the cellular responses to CNDAC, AraC, and CPT (show CHPT1 Antibodies)
Data indicate that the initial step of tyrosyl-DNA phosphodiesterase 1 (Tdp1) interaction with DNA includes binding of Tdp1 to the DNA ends followed by the 3'-nucleosidase reaction.
Data indicate a molecular basis for DNA 3'-end processing by tyrosyl-DNA phosphodiesterase (Tdp1).
Expression of human Tdp1HisnucAla and Tdp1HisgabAsn mutants results in stabilization of the covalent TDP1-DNA intermediate and induces cytotoxicity.
We show that two genes, TDP1, a tyrosyl-DNA-phosphdiesterase, and TAF12 (show TAF12 Antibodies), an RNA polymerase II (show 0 Antibodies) TATA-box binding factor, cause CIN (show PDXP Antibodies) when overexpressed in human cells. Using SDL screens in yeast, we identified a set of genes that when deleted specifically kill cells with high levels of Tdp1
TDP1 participation in human non-homologous end joining (NHEJ) is mediated by interaction with XLF (show NHEJ1 Antibodies), and that TDP1-XLF (show NHEJ1 Antibodies) interactions and subsequent NHEJ events are regulated by phosphorylation of TDP1-S81.
Mutations in TDP1 and APTX have been linked to Spinocerebellar ataxia with axonal neuropathy (SCAN1) and Ataxia-ocular motor apraxia 1 (AOA1), respectively, while mutations in PNKP are considered to be responsible for Microcephaly with seizures (MCSZ) and Ataxia-ocular motor apraxia 4 (AOA4).
The data obtained suggest that PARP1 (show PARP1 Antibodies) and TDP1 bind in an antiparallel orientation; the N-terminus of the former protein interacts with the C-terminal domain of the latter.
Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2alpha cleavage complexes in human cells.
These findings provide evidence for TDP1 as a novel mitochondrial enzyme.
The interaction with Lig3alpha is promoted by serine 81 that is located within a putative S/TQ site in the N-terminus domain of TDP1.
Data indicate that TDP1 is required for neural homeostasis and reveal a widespread requisite for TDP1 function in response to acutely elevated levels of DNA topoisomerase I (Top1 (show TOP1 Antibodies))-associated DNA strand breaks.
This study provides a direct demonstration that Tdp1 repairs Topo I (show TOP1 Antibodies) covalent lesions in vivo and suggests that spinocerebellar ataxia with axonal neuropathy (SCAN1 (show CANT1 Antibodies)) arises from the recessive neomorphic mutation H493R.
Tdp1(-/-) fibroblasts exhibited deficiencies in processing 3'-phosphotyrosyl single-strand breaks and 3'-phosphoglycolate double-strand breaks, but not 3 (show CNOT3 Antibodies)'-phosphoglycolate single-strand breaks.
AtTDP plays a clear role in the repair of topoisomerase I (show TOP1 Antibodies)-DNA complexes.
The protein encoded by this gene is involved in repairing stalled topoisomerase I-DNA complexes by catalyzing the hydrolysis of the phosphodiester bond between the tyrosine residue of topoisomerase I and the 3-prime phosphate of DNA. This protein may also remove glycolate from single-stranded DNA containing 3-prime phosphoglycolate, suggesting a role in repair of free-radical mediated DNA double-strand breaks. This gene is a member of the phospholipase D family and contains two PLD phosphodiesterase domains. Mutations in this gene are associated with the disease spinocerebellar ataxia with axonal neuropathy (SCAN1). While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major variants of this gene and encode the same isoform.
tyr-DNA phosphodiesterase 1
, tyrosyl-DNA Phosphodiesterase (Tdp1)
, protein expressed in male leptotene and zygotene spermatocytes 501
, tyrosyl-DNA phodphodiesterase 1
, tyrosyl-DNA phosphodiesterase 1
, tyrosyl-DNA phosphodiesterase 1-like
, Tyrosyl-DNA phosphodiesterase 1-like protein